144 related articles for article (PubMed ID: 2525981)
1. Profile of etodolac: pharmacokinetic evaluation in special populations.
Brater DC; Lasseter KC
Clin Rheumatol; 1989 Mar; 8 Suppl 1():25-35. PubMed ID: 2525981
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics.
Cadorniga R; Herrero R; Barcia E; Molina IT; Guitierrez JA; Fabregas JL; Martinez-Tobed A
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():389-96. PubMed ID: 1840326
[TBL] [Abstract][Full Text] [Related]
3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
4. A review of the antiarthritic efficacy and safety of etodolac.
Zvaifler N
Clin Rheumatol; 1989 Mar; 8 Suppl 1():43-53. PubMed ID: 2525982
[TBL] [Abstract][Full Text] [Related]
5. Etodolac kinetics in the elderly.
Scatina J; Hicks D; Kraml M; Weidler D; Garg D; Sanda M
Clin Pharmacol Ther; 1986 May; 39(5):550-3. PubMed ID: 2938866
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
Shi JM; Lai SG; Xu CJ; Duan GL; Li D
Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of etodolac in subjects with renal impairment.
Brater DC
Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
[TBL] [Abstract][Full Text] [Related]
8. Etodolac clinical pharmacokinetics.
Brocks DR; Jamali F
Clin Pharmacokinet; 1994 Apr; 26(4):259-74. PubMed ID: 8013160
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of etodolac in special populations.
Benet LZ
Eur J Rheumatol Inflamm; 1994; 14(1):15-8. PubMed ID: 7744123
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective disposition of etodolac enantiomers in synovial fluid.
Brocks DR; Jamali F; Russell AS
J Clin Pharmacol; 1991 Aug; 31(8):741-6. PubMed ID: 1831817
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
Puccetti L; Ciompi ML
Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee.
Astorga Paulsen G; Baigun S; Galvao de Figueiredo J; Gomes de Freitas G
Curr Med Res Opin; 1991; 12(6):401-12. PubMed ID: 1828415
[TBL] [Abstract][Full Text] [Related]
13. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
[TBL] [Abstract][Full Text] [Related]
14. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
[TBL] [Abstract][Full Text] [Related]
15. Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
Pawlotsky Y; Le Dantec P; Jacquelinet C; Lapicque F; Goasguen J; Perdriger A; Veillard E; Guggenbuhl P; Netter P
Rev Rhum Engl Ed; 1996 Mar; 63(3):179-87. PubMed ID: 8731235
[TBL] [Abstract][Full Text] [Related]
16. Chiral bioequivalence: effect of absorption rate on racemic etodolac.
Boni JR; Korth-Bradley JM; Richards LS; Chiang ST; Hicks DR; Benet LZ
Clin Pharmacokinet; 2000 Dec; 39(6):459-69. PubMed ID: 11192477
[TBL] [Abstract][Full Text] [Related]
17. Influence of liver cirrhosis upon the pharmacokinetics of tenoxicam.
Crevoisier C; Zaugg PY; Heizmann P; Meyer J
Int J Clin Pharmacol Res; 1989; 9(5):327-34. PubMed ID: 2625372
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study.
Kato M; Ishizuka H; Taguchi T; Shiosakai K; Kamiyama E; Sata M; Yoshida T
Adv Ther; 2018 Aug; 35(8):1239-1250. PubMed ID: 29968010
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
Manvelian G; Daniels S; Gibofsky A
Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
[TBL] [Abstract][Full Text] [Related]
20. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
Lanza FL; Arnold JD
Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
